Microwave Treatment of Stone Surfaces for the Devitalization of Biodeteriogens

The experimental work described in this paper is aimed at evaluating the possibility of applying microwave heating to a restoration project. The technique involves the application of microwaves to stone surfaces affected by biodeterioration. Results showed that the pests were completely devitalised. The materials chosen for the survey were yellow and grey tuff. Samples of both tuffs were taken in the area of agro nocerino-sarnese and samples of lime mortar and brick were taken from a ruin located in Saint Eustachio (AV). The methodology consists of two phases: in the first, samples of material are placed in a reverberation chamber and treated by varying the parameters of power and exposure time; in the second, they underwent chemical-physical analysis aimed at establishing whether the treatment had induced aesthetic and/or structural alterations. The procedure was performed both on intact samples and on powdered samples for further analysis. Specifically selected and treated samples were subjected to colorimetric analysis, thermogravimetric analysis, of x-ray diffraction, infrared spectroscopy, SEM, and analysis of transport properties and compressive strength. Results from the chemical and structural analyses relating to the samples treated with the protocol showed no differences between the treated and untreated material. The only difference between the two types of material used related to the absorption capacity of water after treatment. From this, it can be deduced that the heating of stone materials using microwaves devitalizes pests, while leaving the substrate unaltered and the microstructure unaffected by any change

Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood

RATIONALE: Due to the invasive nature of the procedures involved, most studies of Mycobacterium tuberculosis (Mtb)-specific immunity in humans have focused on the periphery rather than the site of active infection, the lung. Recently, antigens associated with Mtb-latency and -dormancy have been described using peripheral blood (PB) cells; however their response in the lung is unknown. The objective of this report was to evaluate, in patients prospectively enrolled with suspected active tuberculosis (TB), whether the latency antigen Rv2628 induces local-specific immune response in bronchoalveolar lavage (BAL) cells compared to PB cells. MATERIAL/METHODS: Among the 41 subjects enrolled, 20 resulted with active TB. Among the 21 without active disease, 9 were defined as subjects with latent TB-infection (LTBI) [Quantiferon TB Gold In-tube positive]. Cytokine responses to Rv2628 were evaluated by enzyme linked immunospot (ELISPOT) assay and flow cytometric (FACS) analysis. RD1-secreted antigen stimulation was used as control. RESULTS: There was a significantly higher frequency of Rv2628- and RD1-specific CD4+ T-cells in the BAL of active TB patients than in PB. However the trend of the response to Rv2628 in subjects with LTBI was higher than in active TB in both PB and BAL, although this difference was not significant. In active TB, Rv2628 and RD1 induced a cytokine-response profile mainly consisting of interferon (IFN)-γ-single-positive over double-IFN-γ/interleukin (IL)-2 T-cells in both PB and BAL. Finally, BAL-specific CD4+ T-cells were mostly effector memory (EM), while peripheral T-cell phenotypes were distributed among naïve, central memory and terminally differentiated effector memory T-cells. CONCLUSIONS: In this observational study, we show that there is a high frequency of specific T-cells for Mtb-latency and RD1-secreted antigens (mostly IFN-γ-single-positive specific T-cells with an EM phenotype) in the BAL of active TB patients. These data may be important for better understanding the pathogenesis of TB in the lung

Methylated HBHA produced in <i>M. smegmatis</i> discriminates between active and non-active tuberculosis disease among RD1-responders

Background. A challenge in tuberculosis (TB) research is to develop a new immunological test that can help distinguish, among subjects responsive to QuantiFERON TB Gold In tube (QFT-IT), those who are able to control Mtb replication (remote LTBI, recent infection and past TB) from those who cannot (active TB disease). IFN-γ; response to the Heparin-binding-hemagglutinin (HBHA) of Mtb has been associated with LTBI, but the cumbersome procedures of purifying the methylated and immunological active form of the protein from Mtb or M. bovis Bacillus Calmette et Guerin (BCG) have prevented its implementation in a diagnostic test. Therefore, the aim of the present study was to evaluate the IFN-γ response to methylated HBHA of Mtb produced in M. smegmatis (rHBHAms) in individuals at different stages of TB who scored positive to QFT-IT. Methodology/Principal Findings. 87 individuals at different stages of TB who scored positive to QFT-IT were selected. IFN-γ response to in vitro whole blood stimulation with rHBHAms was evaluated by short-term and long-term tests and detected by ELISA or flow cytometry. We demonstrated that the IFN-γ response to rHBHAms is mediated by CD4+ T-cells with an effector-memory phenotype. This response, evaluated by short-term-tests, is significantly lower in active TB than in remote LTBI (p = 0.0010) and past TB (p = 0.0152). These results were confirmed by long-term tests. The qualitative data confirmed that IFN-γ responses higher than the cut-off point identified by ROC analysis are associated with the status of non-active disease. Conclusions. In this study we show that the T-cell response to a recombinant and methylated HBHA of Mtb produced in M. smegmatis is useful to discriminate between active and non-active TB disease among those responsive to QFT-IT in a whole blood system. Further studies are needed to improve the accuracy of the assay

Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders

A challenge in tuberculosis (TB) research is to develop a new immunological test that can help distinguish, among subjects responsive to QuantiFERON TB Gold In tube (QFT-IT), those who are able to control Mtb replication (remote LTBI, recent infection and past TB) from those who cannot (active TB disease). IFN-\u3b3 response to the Heparin-binding-hemagglutinin (HBHA) of Mtb has been associated with LTBI, but the cumbersome procedures of purifying the methylated and immunological active form of the protein from Mtb or M. bovis Bacillus Calmette et Guerin (BCG) have prevented its implementation in a diagnostic test. Therefore, the aim of the present study was to evaluate the IFN-\u3b3 response to methylated HBHA of Mtb produced in M. smegmatis (rHBHAms) in individuals at different stages of TB who scored positive to QFT-IT

Il bilancio integrato per le PMI

Accanto ai capitali finanziario e produttivo, ogni impresa fonda il proprio business e il proprio successo anche su risorse intangibili, quali il capitale intellettuale, il capitale umano, il capitale sociale e relazionale ed il capitale naturale. Il tradizionale bilancio economico-finanziario, però, non è adatto a valutare e rappresentare tali risorse, poiché è stato concepito con riferimento ad un’economia industriale fondata pressoché esclusivamente su capitali tangibili; pertanto, anche avuto riguardo alla realtà delle PMI, si rende oggi necessario introdurre nuovi strumenti e nuovi indicatori per la misurazione e la rendicontazione, che siano in grado di cogliere e valorizzare anche le componenti immateriali del capitale aziendale. In questo contesto, il bilancio integrato si pone come una forma evoluta di comunicazione aziendale, finalizzata ad illustrare come strategia, governance, modello di business, rapporti con gli stakeholder, performance passate e prospettive future, rischi e opportunità consentano anche ad un’impresa di piccole e medie dimensioni di creare valore nel breve, medio e lungo termine

Infezione da streptococco di Gruppo B in gravidanza: management delle pazienti con storia di allergia alla penicillina

Introduzione: l’infezione da streptococco di gruppo B in gravidanza è associata a importanti conseguenze, sia materne che neonatali. Materiali e metodi: il nostro studio ha coinvolto 45 gravide tra 35 e 37 settimane di gestazione, con tampone vagino-rettale positivo per streptococco di gruppo B e storia di allergia alla penicillina di tipo non anafilattico. Scopo del nostro studio è stato di dimostrare che parte di tali donne potevano ricevere comunque la penicillina in travaglio, in quanto negative ai test cutanei per l’allergia alla penicillina. Risultati: delle 45 donne in esame, 2 sono state escluse per storia di anafilassi alla penicillina, 43 sono state sottoposte a prick test; di queste, 40 sono risultate negative al prick test e sottoposte al test intradermico, anch’esso risultato negativo. Queste ultime in travaglio sono state trattate prima con una dose orale di penicillina V e non avendo avuto reazioni avverse, hanno ricevuto penicillina G ev. Le 3 donne positive al prick test e le 2 escluse per anafilassi sono state trattate con protocollo alternativo perché ad alto rischio di anafilassi. Conclusioni: 40 donne su 45 (89%) hanno ottimizzato la chemioprofilassi ricevendo penicillina G in termini di migliore sensibilità del batterio all’antibiotico, migliori concentrazioni transplacentari dell’antibiotico, minore costo della terapia, diminuzione di ceppi resistenti ad antibiotici alternativi alla penicillina

Nets building Blocks

Los Angeles US